Literature DB >> 34343911

Binding kinetics of liposome conjugated E-selectin and P-selectin glycoprotein ligand-1 measured with atomic force microscopy.

Yuyuan Zhou1, Wenpeng Cao1, Zhiliang Xu2, X Frank Zhang3, Yaling Liu4.   

Abstract

Various ligand-functionalized liposomes have been developed for targeted therapies. Typically, the binding properties of the ligands and targeted proteins are measured with surface plasmon resonance (SPR), where the proteins are immobilized on a rigid surface. However, the difference of protein-ligand binding kinetics between liposome-conjugated protein and rigid surface-conjugated protein is not fully understood. In this work, the binding kinetics of P-selectin glycoprotein ligand-1 (PSGL-1) and E-selectin conjugated on liposome and on rigid surfaces are investigated with Atomic Force Microscopy (AFM). The results suggest that protein orientation and diffusion on liposomal membrane can alter the binding kinetics of the protein-ligand interaction. Specifically, the association and dissociation rate constant of AFM probe-conjugated E-selectin and glass-conjugated PSGL-1 are measured as 9.32 × 104 M-1s-1 and 1.54 s-1, respectively. While for the liposome-conjugated E-selectin and glass-conjugated PSGL-1, the kinetic constants are measured as 5.00 × 107 M-1s-1 and 2.76 s-1, respectively. Thus, there is an order's magnitude increase of binding affinity (from kd = 16.51 μM to kd = 0.06 μM) when protein is attached to liposome compared to attached to a rigid surface. The results might provide better understanding and pave the way for the future design of the ligand-targeted liposomes.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atomic force microscopy; Binding affinity; Binding kinetics; E-selectin; Liposome

Mesh:

Substances:

Year:  2021        PMID: 34343911      PMCID: PMC8487949          DOI: 10.1016/j.colsurfb.2021.112002

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  31 in total

1.  The X-ray three-dimensional structure of avidin.

Authors:  C Rosano; P Arosio; M Bolognesi
Journal:  Biomol Eng       Date:  1999-12-31

2.  Quantifying the effects of molecular orientation and length on two-dimensional receptor-ligand binding kinetics.

Authors:  Jun Huang; Juan Chen; Scott E Chesla; Tadayuki Yago; Padmaja Mehta; Rodger P McEver; Cheng Zhu; Mian Long
Journal:  J Biol Chem       Date:  2004-08-06       Impact factor: 5.157

3.  Binding constants of membrane-anchored receptors and ligands: A general theory corroborated by Monte Carlo simulations.

Authors:  Guang-Kui Xu; Jinglei Hu; Reinhard Lipowsky; Thomas R Weikl
Journal:  J Chem Phys       Date:  2015-12-28       Impact factor: 3.488

4.  Protein-Protein Interactions: Surface Plasmon Resonance.

Authors:  Badreddine Douzi
Journal:  Methods Mol Biol       Date:  2017

Review 5.  Protein-ligand (un)binding kinetics as a new paradigm for drug discovery at the crossroad between experiments and modelling.

Authors:  M Bernetti; A Cavalli; L Mollica
Journal:  Medchemcomm       Date:  2017-01-30       Impact factor: 3.597

6.  Detection and localization of individual antibody-antigen recognition events by atomic force microscopy.

Authors:  P Hinterdorfer; W Baumgartner; H J Gruber; K Schilcher; H Schindler
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

Review 7.  Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic.

Authors:  Anu Puri; Kristin Loomis; Brandon Smith; Jae-Ho Lee; Amichai Yavlovich; Eliahu Heldman; Robert Blumenthal
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  2009       Impact factor: 4.889

8.  Affinity and kinetic analysis of L-selectin (CD62L) binding to glycosylation-dependent cell-adhesion molecule-1.

Authors:  M W Nicholson; A N Barclay; M S Singer; S D Rosen; P A van der Merwe
Journal:  J Biol Chem       Date:  1998-01-09       Impact factor: 5.157

9.  Improved outcome when B-cell lymphoma is treated with combinations of immunoliposomal anticancer drugs targeted to both the CD19 and CD20 epitopes.

Authors:  Puja Sapra; Theresa M Allen
Journal:  Clin Cancer Res       Date:  2004-04-01       Impact factor: 12.531

Review 10.  Advances and Challenges of Liposome Assisted Drug Delivery.

Authors:  Lisa Sercombe; Tejaswi Veerati; Fatemeh Moheimani; Sherry Y Wu; Anil K Sood; Susan Hua
Journal:  Front Pharmacol       Date:  2015-12-01       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.